UA95646C2 - Vaccine comprising adjuvant based on oil in water emulsion - Google Patents

Vaccine comprising adjuvant based on oil in water emulsion

Info

Publication number
UA95646C2
UA95646C2 UAA200902223A UAA200902223A UA95646C2 UA 95646 C2 UA95646 C2 UA 95646C2 UA A200902223 A UAA200902223 A UA A200902223A UA A200902223 A UAA200902223 A UA A200902223A UA 95646 C2 UA95646 C2 UA 95646C2
Authority
UA
Ukraine
Prior art keywords
oil
water emulsion
vaccine
adjuvant based
composition
Prior art date
Application number
UAA200902223A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Вилльям Рипли Джуниор Баллоу
Эммануэль Джулс Ганон
Original Assignee
ГлаксоСмитКлайн Байолоджикалз с.а.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ГлаксоСмитКлайн Байолоджикалз с.а. filed Critical ГлаксоСмитКлайн Байолоджикалз с.а.
Publication of UA95646C2 publication Critical patent/UA95646C2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides an immunogenic composition comprising an antigen or antigen composition and an adjuvant composition comprising an oil in water emulsion, wherein said oil in water emulsion comprises 0.5 -10 mg metabolisable oil, 0.5-11 mg tocol and 0.1 - 4 mg emulsifying agent, per human dose.
UAA200902223A 2006-10-12 2007-10-10 Vaccine comprising adjuvant based on oil in water emulsion UA95646C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0620336.8A GB0620336D0 (en) 2006-10-12 2006-10-12 Vaccine

Publications (1)

Publication Number Publication Date
UA95646C2 true UA95646C2 (en) 2011-08-25

Family

ID=37491460

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200902223A UA95646C2 (en) 2006-10-12 2007-10-10 Vaccine comprising adjuvant based on oil in water emulsion

Country Status (4)

Country Link
ES (1) ES2369604T3 (en)
GB (1) GB0620336D0 (en)
UA (1) UA95646C2 (en)
ZA (1) ZA200902027B (en)

Also Published As

Publication number Publication date
ES2369604T3 (en) 2011-12-02
ZA200902027B (en) 2010-06-30
GB0620336D0 (en) 2006-11-22

Similar Documents

Publication Publication Date Title
MX2009003325A (en) Vaccine comprising an oil in water emulsion adjuvant.
EP2455101A3 (en) Influenza vaccine with oil-in-water emulsion adjuvant
CY1116904T1 (en) VACCINE
UA100507C2 (en) Prevention and treatment of sub-clinical pcvd
MX2009011708A (en) Surfactant-free foam formulations.
TW200700079A (en) Composition
IL214325A (en) Anti-cmet antibody, composition comprising it and use thereof
MX2009001412A (en) Protein matrix vaccines and methods of making and administering such vaccines.
CR10101A (en) NEW COMPOSITION
ECSP077238A (en) COMPOSITIONS FOR DELIVERY OF HIGHLY SOLUBLE DRUGS IN WATER
ATE426412T1 (en) ADJUVANT INFLUENZA VACCINE
MX2009008928A (en) Compositions comprising polysaccharide conjugates and their use as vaccines.
NZ700477A (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
MA29459B1 (en) VACCINES
TW200633719A (en) Glycoconjugate vaccines containing peptidoglycan
WO2006071983A3 (en) Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
WO2007078879A3 (en) Lipopeptide compositions and methods of use thereof
EA201001478A1 (en) VACCINE
MX2009011384A (en) Adjuvant combinations of nkt activator, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity.
WO2008008541A8 (en) Methods to elicit, enhance and sustain immune responses against mhc class-i restricted epitopes, for prophylactic or therapeutic purposes
GB2444676A (en) Adjuvanted vaccine
EP2433648A3 (en) Vaccine comprising an oil in water emulsion adjuvant
WO2007120603A3 (en) Immunogenic bcr-abl peptides and methods of use thereof
UA95646C2 (en) Vaccine comprising adjuvant based on oil in water emulsion
BR0111785A (en) Compositions and methods for treating candidiasis